St. Louis School of Medicine: Drug combo therapy in mice blocks drug resistance, halts tumor growth
September 01, 2022
September 01, 2022
ST. LOUIS, Missouri, Sept. 1 (TNSjou) -- The Washington University St. Louis School of Medicine issued the following news release:
* * *
May lead to better treatments for deadliest form of lung cancer
* * *
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis, Grenoble Alp . . .
* * *
May lead to better treatments for deadliest form of lung cancer
* * *
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis, Grenoble Alp . . .